Adverum Biotechnologies Inc (ADVM) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ADVM.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
ADVM Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ADVM has a less percent of analysts bearish on the stock than just about 100% of all US stocks.
- ADVM has a greater number of analysts covering the stock than 85.82% of stocks in the small market cap category.
- The upside potential (average analyst target price relative to current price) of ADVM is greater than 84.68% of all US stocks.
- The variance in analysts' estimates of ADVM is less than 19.27% of stocks in the small market cap category.
- ADVM has a higher percentage of analysts bullish on the stock than 78.53% of all US stocks.
- ADVM has a greater average analyst price target than 68.44% of stocks in the small market cap category.
- ADVM has a lower change in bullishness amongst analysts than just about 100% of all US stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Adverum Biotechnologies Inc are ZEAL, TRIL and HCM.
Make investment decisions regarding ADVM using the data that counts. Try POWR Ratings for free.